The 15th Vogel Pharmaceutical Engineering International Forum was grandly held in Nanjing, China from December 11th to December 12th, 2023. During the forum, the highly anticipated “PharmaTEC Pharmaceutical Industry 20th Anniversary Celebration and Pharmaceutical Industry Award Selection” was grandly announced, and Canaan Technology was awarded the “Outstanding Enterprise Award”, injecting more innovative momentum and strong exemplary force into the industry.

The “Excellent Enterprise” award is awarded to recognize pharmaceutical equipment enterprises with high-quality innovation, significant industry status, and good main business of the company. Canaan Technology has received this honor, highlighting the industry’s continued attention and recognition of Canaan Technology.
Based on the new development stage, implementing the new development concept, constructing a new development pattern, and promoting high-quality development are the core value orientation of the development of the pharmaceutical equipment industry in the new era.
Canaan Technology has always adhered to the core values of “integrity, innovation, win-win cooperation, and excellence for the future”. In the new era of transformation and upgrading of China’s pharmaceutical equipment industry, a large number of enterprises pursuing excellence are becoming pioneers, practitioners, and leaders in the high-quality development of China’s pharmaceutical equipment industry. Canaan Technology is the practitioner of seizing opportunities and advancing in this rolling wave.

Adhering to integrity and innovation, daring to explore new pathsThe significant transformation from “single machine” to “whole line” and the integration of “dosage+API” equipment has continuously sparked brilliant sparks in new fields, adhering to the purpose of “continuity, intelligence, sealing, integration, and greening”. By leveraging its technological advantages, integrating resources, and helping pharmaceutical companies customize rational system solutions, while improving efficiency, it saves operating costs and enables enterprises to meet existing needs at a lower cost. By providing one-stop services covering the entire life cycle of drugs, it helps the pharmaceutical industry achieve digital transformation.

Collaborative and win-win, sharing responsibility and honorSince its establishment, Canaan Technology has been forging ahead on the path of becoming a core enterprise, continuously improving its own industrial chain development resilience through stable and fixed chains. At the same time, it actively builds a supply chain platform, deeply binds with upstream and downstream enterprises in the industrial chain, and “uses their strengths to make up for their shortcomings”. In the process of linking, it achieves the lowest cost, highest efficiency, and maximum value of mutual benefit and win-win, helping industrial clusters and collaborative development of a “win-win chain”.

Strive for excellence and create a new chapter towards excellenceCanaan Technology has been focusing on the digitalization of pharmaceutical equipment, with the rapid development of new generation information technology such as big data, AI, industrial Internet, etc. Canaan Technology accelerates the pace of transformation and upgrading. Through industrial Internet integration, industrial control software, industrial cloud and data mining technology, it builds software and hardware systems of intelligent production mode, deeply integrates with advanced drug production equipment and automatic control system to achieve integration of management and control, and creates an intelligent production mode throughout the whole life cycle of modern drugs, which will inject power into the realization of real “intelligent manufacturing” in the pharmaceutical industry.

In the future, Canaan Technology will continue to focus on the pharmaceutical equipment field, anchor a new starting point for digital transformation, fully unleash its business and product portfolio, actively promote independent research and development, and be committed to promoting pharmaceutical technology upgrades to effectively safeguard drug safety and meet the urgent needs of pharmaceutical enterprises. .